Pre-made Mibavademab biosimilar (Whole mAb, anti-LEPR therapeutic antibody, Anti-CD295/LEPRD/OB-R/OBR Antibody) - benchmark reference antibody

Cat:GMP-Bios-ab-343

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-343 Category Tag

Product Details

Pre-made Mibavademab biosimilar (Whole mAb, anti-LEPR therapeutic antibody, Anti-CD295/LEPRD/OB-R/OBR Antibody) – benchmark reference antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Products Name (INN Index)

Pre-Made Mibavademab biosimilar, Whole mAb, Anti-LEPR Antibody: Anti-CD295/OB-R/OBR therapeutic antibody

INN Name

Mibavademab

Target

LEPR

Format

Whole mAb

Derivation

NA

Species Reactivity

Human

CH1 Isotype

IgG4

VD LC

Kappa

Highest_Clin_Trial (Jan '20)

Phase-II

Est. Status

Active

100% SI Structure

None

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2020

Companies

Regeneron Pharmaceuticals

Conditions Approved

NA

Conditions Active

Lipodystrophy

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

LEPR

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide